MCP-1 and CCR2 gene polymorphisms in Parkinson’s disease in a Han Chinese cohort
详细信息 查看全文
- 作者：Liang Gao ; Hongmei Tang ; Kun Nie ; Limin Wang ; Jiehao Zhao…
- 关键词：Parkinson’s disease ; MCP ; 1 ; CCR2 ; Gene polymorphism ; Cognitive impairment ; Depression
- 刊名：Neurological Sciences
- 出版年：2015
- 出版时间：April 2015
- 年：2015
- 卷：36
- 期：4
- 页码：571-576
- 全文大小：180 KB
- 参考文献：1. Kannarkat, GT, Boss, JM, Tansey, MG (2013) The role of innate and adaptive immunity in Parkinson’s disease. J Parkinsons Dis 3: pp. 493-514
2. Amor, S, Peferoen, LA, Vogel, DY, Breur, M, Valk, P, Baker, D, Noort, JM (2013) Inflammation in neurodegenerative diseases—an update. Immunology 142: pp. 151-166 CrossRef
3. Bajetto, A, Bonavia, R, Barbero, S, Florio, T, Schettini, G (2001) Chemokines and their receptors in the central nervous system. Front Neuroendocrinol 22: pp. 147-184 CrossRef
4. Bose, S, Cho, J (2013) Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases. Arch Pharm Res 36: pp. 1039-1050 CrossRef
5. Conductier, G, Blondeau, N, Guyon, A, Nahon, JL, Rovere, C (2010) The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J Neuroimmunol 224: pp. 93-100 CrossRef
6. Pattarini, R, Smeyne, RJ, Morgan, JI (2007) Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson’s disease. Neuroscience 145: pp. 654-668 CrossRef
7. Reale, M, Iarlori, C, Thomas, A, Gambi, D, Perfetti, B, Nicola, M, Onofrj, M (2009) Peripheral cytokines profile in Parkinson’s disease. Brain Behav Immun 23: pp. 55-63 CrossRef
8. Lindqvist, D, Hall, S, Surova, Y, Nielsen, HM, Janelidze, S, Brundin, L, Hansson, O (2013) Cerebrospinal fluid inflammatory markers in Parkinson’s disease–associations with depression, fatigue, and cognitive impairment. Brain Behav Immun 33: pp. 183-189 CrossRef
9. Nishimura, M, Kuno, S, Mizuta, I, Ohta, M, Maruyama, H, Kaji, R, Kawakami, H (2003) Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson’s disease. Mov Disord 18: pp. 953-955 CrossRef
10. Pola, R, Flex, A, Gaetani, E, Proia, AS, Papaleo, P, Giorgio, A (2004) Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer’s disease in Italians. Exp Gerontol 39: pp. 1249-1252 CrossRef
11. Galimberti, D, Fenoglio, C, Lovati, C, Gatti, A, Guidi, I, Venturelli, E (2004) CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer’s disease. J Neurol Sci 225: pp. 79-83 CrossRef
12. Pae, CU, Chung, KI, Kim, JJ, Yu, HS, Lee, CU, Lee, SJ (2004) Monocyte chemoattractant protein-1 promoter -2518 polymorphism and schizophrenia in the Korean population. Psychiatr Genet 14: pp. 65-67 CrossRef
13. Daniel, SE, Lees, AJ (1993) Parkinson’s Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 39: pp. 165-172
14. Nie, K, Zhang, Y, Gan, R, Wang, L, Zhao, J, Huang, Z (2013) Polymorphisms in immune/inflammatory cytokine genes are related to Parkinson’s disease with cognitive impairment in the Han Chinese population. Neurosci Lett 541: pp. 111-115 CrossRef
15. Guyon, A, Skrzydelski, D, Giry, I, Rovere, C, Conductier, G, Trocello, JM (2009) Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. Neuroscience 162: pp. 1072-1080 CrossRef
16. Huerta, C, Alvarez, V, Mata, IF, Coto, E, Ribacoba, R, Martinez, C (2004) Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer’s and Parkinson’s disease. Neurosci Lett 370: pp. 151-154
文摘
Monocyte chemoattractant protein-1 (MCP-1) and its receptor CC chemokine receptor-2 (CCR2) play important roles in neuroinflammation and they have been shown to be involved in Parkinson’s disease (PD) pathogenesis. In addition, several studies have suggested a role for the MCP-1 and CCR2 genotypes in cognitive impairment and depression, which are common non-motor symptoms in PD patients. In this study, a cohort of 521 PD patients and 556 cases of healthy controls were recruited to investigate the association between the MCP-1 2518A/G (rs1064211) and CCR2 V64I (rs1799864) gene polymorphisms and PD risk in the Chinese population. We also analyze the influence of these genotypes on the cognitive function and depression in PD patients by comparing Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Wechsler Adult Intelligence Scale-Chinese Revision (WAIS-RC), Wechsler Memory Scale-Chinese Revision (WMS-RC) and Hamilton Depression Rating Scale (HAMD) ratings in 217 PD patients. Our results showed no significant differences in the genotype frequency between the PD group and the control group (P?>?0.05). In addition, we also failed to find an influence of the MCP-1 and CCR2 genotypes on MMSE scores, MoCA scores, WAIS-RC scores, WMS-RC scores and HAMD scores in PD patients (P?>?0.05). The MCP-1 and CCR2 gene polymorphisms may not be genetic risk factors for PD in the Han Chinese population, and they do not appear to influence cognitive function and depression in PD patients.